Loading…
What is the use of hemovigilance?
The French Blood Agency has developed a national system of surveillance and alert, from blood collection to the follow-up of the recipients, called haemovigilance. The French haemovigilance network is now operational, and aims at detecting, gathering and analysing unexpected or undesirable effects a...
Saved in:
| Published in: | Transfusion clinique et biologique : journal de la Société française de transfusion sanguine 1998-12, Vol.5 (6), p.415-421 |
|---|---|
| Main Authors: | , |
| Format: | Article |
| Language: | fre |
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | |
|---|---|
| cites | |
| container_end_page | 421 |
| container_issue | 6 |
| container_start_page | 415 |
| container_title | Transfusion clinique et biologique : journal de la Société française de transfusion sanguine |
| container_volume | 5 |
| creator | Quaranta, J F Canivet, N |
| description | The French Blood Agency has developed a national system of surveillance and alert, from blood collection to the follow-up of the recipients, called haemovigilance. The French haemovigilance network is now operational, and aims at detecting, gathering and analysing unexpected or undesirable effects associated with transfusion in order to remedy their causes and prevent their recurrence. Thanks to 1) traceability of blood products from donors to recipients, 2) spontaneous reports of transfusion adverse events, and 3) rigorous management of information related to the transfusion process, haemovigilance effectively contributes to blood transfusion safety. |
| format | article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_69138591</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69138591</sourcerecordid><originalsourceid>FETCH-LOGICAL-p533-b8efefc34df486b25ce0d054bc4d26926eee26eea223157e9018c887ad01510a3</originalsourceid><addsrcrecordid>eNotj8FKxDAURbNQxrH6CULcuCskeUmarEQGdYQBNwMuS5q82Ehra9MK_r0jdnPu5nK494xsuZC6rIxgF-Qy5w_GeMVttSEba6wEgC25fWvdTFOmc4t0yUiHSFvsh-_0njr36fH-ipxH12W8XrMgx6fH425fHl6fX3YPh3JUAGVjMGL0IEOURjdCeWSBKdl4GYS2QiPiH5wQwFWFlnHjjalcYFxx5qAgd__acRq-Fsxz3afssTuNwGHJtbYcjDqhIDdrcWl6DPU4pd5NP_V6CX4Bi_NFAg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69138591</pqid></control><display><type>article</type><title>What is the use of hemovigilance?</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Quaranta, J F ; Canivet, N</creator><creatorcontrib>Quaranta, J F ; Canivet, N</creatorcontrib><description>The French Blood Agency has developed a national system of surveillance and alert, from blood collection to the follow-up of the recipients, called haemovigilance. The French haemovigilance network is now operational, and aims at detecting, gathering and analysing unexpected or undesirable effects associated with transfusion in order to remedy their causes and prevent their recurrence. Thanks to 1) traceability of blood products from donors to recipients, 2) spontaneous reports of transfusion adverse events, and 3) rigorous management of information related to the transfusion process, haemovigilance effectively contributes to blood transfusion safety.</description><identifier>ISSN: 1246-7820</identifier><identifier>PMID: 9894333</identifier><language>fre</language><publisher>France</publisher><subject><![CDATA[Blood Banks - legislation & jurisprudence ; Blood Banks - organization & administration ; Blood Banks - standards ; Communicable Disease Control - organization & administration ; Contact Tracing ; Forms and Records Control ; France - epidemiology ; Humans ; Infection - epidemiology ; Infection - transmission ; Medical Errors ; Quality Assurance, Health Care - organization & administration ; Risk Management - legislation & jurisprudence ; Risk Management - organization & administration ; Transfusion Reaction]]></subject><ispartof>Transfusion clinique et biologique : journal de la Société française de transfusion sanguine, 1998-12, Vol.5 (6), p.415-421</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9894333$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Quaranta, J F</creatorcontrib><creatorcontrib>Canivet, N</creatorcontrib><title>What is the use of hemovigilance?</title><title>Transfusion clinique et biologique : journal de la Société française de transfusion sanguine</title><addtitle>Transfus Clin Biol</addtitle><description>The French Blood Agency has developed a national system of surveillance and alert, from blood collection to the follow-up of the recipients, called haemovigilance. The French haemovigilance network is now operational, and aims at detecting, gathering and analysing unexpected or undesirable effects associated with transfusion in order to remedy their causes and prevent their recurrence. Thanks to 1) traceability of blood products from donors to recipients, 2) spontaneous reports of transfusion adverse events, and 3) rigorous management of information related to the transfusion process, haemovigilance effectively contributes to blood transfusion safety.</description><subject>Blood Banks - legislation & jurisprudence</subject><subject>Blood Banks - organization & administration</subject><subject>Blood Banks - standards</subject><subject>Communicable Disease Control - organization & administration</subject><subject>Contact Tracing</subject><subject>Forms and Records Control</subject><subject>France - epidemiology</subject><subject>Humans</subject><subject>Infection - epidemiology</subject><subject>Infection - transmission</subject><subject>Medical Errors</subject><subject>Quality Assurance, Health Care - organization & administration</subject><subject>Risk Management - legislation & jurisprudence</subject><subject>Risk Management - organization & administration</subject><subject>Transfusion Reaction</subject><issn>1246-7820</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNotj8FKxDAURbNQxrH6CULcuCskeUmarEQGdYQBNwMuS5q82Ehra9MK_r0jdnPu5nK494xsuZC6rIxgF-Qy5w_GeMVttSEba6wEgC25fWvdTFOmc4t0yUiHSFvsh-_0njr36fH-ipxH12W8XrMgx6fH425fHl6fX3YPh3JUAGVjMGL0IEOURjdCeWSBKdl4GYS2QiPiH5wQwFWFlnHjjalcYFxx5qAgd__acRq-Fsxz3afssTuNwGHJtbYcjDqhIDdrcWl6DPU4pd5NP_V6CX4Bi_NFAg</recordid><startdate>199812</startdate><enddate>199812</enddate><creator>Quaranta, J F</creator><creator>Canivet, N</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>199812</creationdate><title>What is the use of hemovigilance?</title><author>Quaranta, J F ; Canivet, N</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p533-b8efefc34df486b25ce0d054bc4d26926eee26eea223157e9018c887ad01510a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>fre</language><creationdate>1998</creationdate><topic>Blood Banks - legislation & jurisprudence</topic><topic>Blood Banks - organization & administration</topic><topic>Blood Banks - standards</topic><topic>Communicable Disease Control - organization & administration</topic><topic>Contact Tracing</topic><topic>Forms and Records Control</topic><topic>France - epidemiology</topic><topic>Humans</topic><topic>Infection - epidemiology</topic><topic>Infection - transmission</topic><topic>Medical Errors</topic><topic>Quality Assurance, Health Care - organization & administration</topic><topic>Risk Management - legislation & jurisprudence</topic><topic>Risk Management - organization & administration</topic><topic>Transfusion Reaction</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Quaranta, J F</creatorcontrib><creatorcontrib>Canivet, N</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Transfusion clinique et biologique : journal de la Société française de transfusion sanguine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Quaranta, J F</au><au>Canivet, N</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>What is the use of hemovigilance?</atitle><jtitle>Transfusion clinique et biologique : journal de la Société française de transfusion sanguine</jtitle><addtitle>Transfus Clin Biol</addtitle><date>1998-12</date><risdate>1998</risdate><volume>5</volume><issue>6</issue><spage>415</spage><epage>421</epage><pages>415-421</pages><issn>1246-7820</issn><abstract>The French Blood Agency has developed a national system of surveillance and alert, from blood collection to the follow-up of the recipients, called haemovigilance. The French haemovigilance network is now operational, and aims at detecting, gathering and analysing unexpected or undesirable effects associated with transfusion in order to remedy their causes and prevent their recurrence. Thanks to 1) traceability of blood products from donors to recipients, 2) spontaneous reports of transfusion adverse events, and 3) rigorous management of information related to the transfusion process, haemovigilance effectively contributes to blood transfusion safety.</abstract><cop>France</cop><pmid>9894333</pmid><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1246-7820 |
| ispartof | Transfusion clinique et biologique : journal de la Société française de transfusion sanguine, 1998-12, Vol.5 (6), p.415-421 |
| issn | 1246-7820 |
| language | fre |
| recordid | cdi_proquest_miscellaneous_69138591 |
| source | ScienceDirect Freedom Collection 2022-2024 |
| subjects | Blood Banks - legislation & jurisprudence Blood Banks - organization & administration Blood Banks - standards Communicable Disease Control - organization & administration Contact Tracing Forms and Records Control France - epidemiology Humans Infection - epidemiology Infection - transmission Medical Errors Quality Assurance, Health Care - organization & administration Risk Management - legislation & jurisprudence Risk Management - organization & administration Transfusion Reaction |
| title | What is the use of hemovigilance? |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T11%3A14%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=What%20is%20the%20use%20of%20hemovigilance?&rft.jtitle=Transfusion%20clinique%20et%20biologique%20:%20journal%20de%20la%20Soci%C3%A9t%C3%A9%20fran%C3%A7aise%20de%20transfusion%20sanguine&rft.au=Quaranta,%20J%20F&rft.date=1998-12&rft.volume=5&rft.issue=6&rft.spage=415&rft.epage=421&rft.pages=415-421&rft.issn=1246-7820&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E69138591%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p533-b8efefc34df486b25ce0d054bc4d26926eee26eea223157e9018c887ad01510a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=69138591&rft_id=info:pmid/9894333&rfr_iscdi=true |